🚀 VC round data is live in beta, check it out!
PACS Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for PACS Group and similar public comparables like RadNet, Option Care Health, Ramsay Health, Bumrungrad Hospital and more.
PACS Group Overview
About PACS Group
PACS Group Inc is a post-acute healthcare company mainly focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.
Founded
2023
HQ
Employees
45.7K
Website
Sectors
Financials (LTM)
EV
$9B
PACS Group Financials
PACS Group reported last 12-month revenue of $5B and EBITDA of $520M.
In the same LTM period, PACS Group generated $1B in gross profit, $520M in EBITDA, and $227M in net income.
Revenue (LTM)
PACS Group P&L
In the most recent fiscal year, PACS Group reported revenue of $5B and EBITDA of $505M.
PACS Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $5B | XXX | $5B | XXX | XXX | XXX |
| Gross Profit | $1B | XXX | $780M | XXX | XXX | XXX |
| Gross Margin | 22% | XXX | 15% | XXX | XXX | XXX |
| EBITDA | $520M | XXX | $505M | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | 10% | XXX | XXX | XXX |
| EBIT Margin | 9% | XXX | 9% | XXX | XXX | XXX |
| Net Profit | $227M | XXX | $192M | XXX | XXX | XXX |
| Net Margin | 4% | XXX | 4% | XXX | XXX | XXX |
| Net Debt | — | — | $152M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
PACS Group Stock Performance
PACS Group has current market cap of $6B, and enterprise value of $9B.
Market Cap Evolution
PACS Group's stock price is $36.51.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $9B | $6B | 0.0% | XXX | XXX | XXX | $1.22 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPACS Group Valuation Multiples
PACS Group trades at 1.6x EV/Revenue multiple, and 17.0x EV/EBITDA.
EV / Revenue (LTM)
PACS Group Financial Valuation Multiples
As of March 27, 2026, PACS Group has market cap of $6B and EV of $9B.
Equity research analysts estimate PACS Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
PACS Group has a P/E ratio of 25.1x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $6B | XXX | $6B | XXX | XXX | XXX |
| EV (current) | $9B | XXX | $9B | XXX | XXX | XXX |
| EV/Revenue | 1.6x | XXX | 1.7x | XXX | XXX | XXX |
| EV/EBITDA | 17.0x | XXX | 17.5x | XXX | XXX | XXX |
| EV/EBIT | 19.0x | XXX | 19.5x | XXX | XXX | XXX |
| EV/Gross Profit | 7.4x | XXX | 11.3x | XXX | XXX | XXX |
| P/E | 25.1x | XXX | 29.9x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 56.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified PACS Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
PACS Group Margins & Growth Rates
PACS Group's revenue in the last 12 month grew by 8%.
PACS Group's revenue per employee in the last FY averaged $0.1M.
PACS Group's rule of 40 is 18% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
PACS Group's rule of X is 30% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
PACS Group Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 8% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | 10% | XXX | XXX | XXX |
| EBITDA Growth | 12% | XXX | 12% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 18% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 30% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| G&A Expenses to Revenue | 7% | XXX | 8% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 9% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
PACS Group Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| RadNet | XXX | XXX | XXX | XXX | XXX | XXX |
| Option Care Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Bumrungrad Hospital | XXX | XXX | XXX | XXX | XXX | XXX |
| Fortis Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
PACS Group M&A Activity
PACS Group acquired XXX companies to date.
Last acquisition by PACS Group was on XXXXXXXX, XXXXX. PACS Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by PACS Group
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialPACS Group Investment Activity
PACS Group invested in XXX companies to date.
PACS Group made its latest investment on XXXXXXXX, XXXXX. PACS Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by PACS Group
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout PACS Group
| When was PACS Group founded? | PACS Group was founded in 2023. |
| Where is PACS Group headquartered? | PACS Group is headquartered in United States. |
| How many employees does PACS Group have? | As of today, PACS Group has over 45K employees. |
| Who is the CEO of PACS Group? | PACS Group's CEO is Jason Murray. |
| Is PACS Group publicly listed? | Yes, PACS Group is a public company listed on NYSE. |
| What is the stock symbol of PACS Group? | PACS Group trades under PACS ticker. |
| When did PACS Group go public? | PACS Group went public in 2024. |
| Who are competitors of PACS Group? | PACS Group main competitors are RadNet, Option Care Health, Ramsay Health, Bumrungrad Hospital. |
| What is the current market cap of PACS Group? | PACS Group's current market cap is $6B. |
| What is the current revenue of PACS Group? | PACS Group's last 12 months revenue is $5B. |
| What is the current revenue growth of PACS Group? | PACS Group revenue growth (NTM/LTM) is 8%. |
| What is the current EV/Revenue multiple of PACS Group? | Current revenue multiple of PACS Group is 1.6x. |
| Is PACS Group profitable? | Yes, PACS Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of PACS Group? | PACS Group's last 12 months EBITDA is $520M. |
| What is PACS Group's EBITDA margin? | PACS Group's last 12 months EBITDA margin is 10%. |
| What is the current EV/EBITDA multiple of PACS Group? | Current EBITDA multiple of PACS Group is 17.0x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.